Wow you are really going to the trouble of splitting semantic hairs in order to make a point. It was fortuitous for AMGN because they saw an opportunity and took it. Enbrel is a multi-billion annual seller. That acquisition was several years ago. Even with the split going to WYE, I think it's seen as a moneymaker for AMGN. But if you want to devote some hours to the exercise of finding all the numbers and then calculating the NPV, go ahead.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.